Compounded D-cycloserine troche prepared per prescriber direction for individualized neurological and psychiatric care planning. Prescription required.
D-Cycloserine Troche is a compounded dosage form prepared by HDRx according to individualized prescriber specifications, including customized strength and flavoring when appropriate. A valid prescription from a licensed healthcare provider is required.
D-Cycloserine may be incorporated into provider-directed neurological or psychiatric care plans when clinically appropriate. A troche (lozenge) is designed for placement in the mouth, allowing absorption through the oral mucosa as directed by the prescribing professional.
Compounding enables healthcare providers to tailor dosage strength and delivery format based on individualized monitoring and clinical considerations.
HDRx collaborates with healthcare providers to support specialized medication planning across multiple care settings. Learn more about emerging clinical discussions involving D-cycloserine and neurological care approaches in our article on D-cycloserine and transcranial magnetic stimulation (TMS).
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their licensed healthcare provider to determine whether this formulation is appropriate for their individual care plan.
